725174746	725174746	CD	B-NP	O
|	|	NN	I-NP	O
NTH	NTH	NN	I-NP	O
|	|	NN	I-NP	O
87507495	87507495	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4438746	4438746	CD	B-NP	O
|	|	CC	I-NP	O
7/6/2003	7/6/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CELLULITIS	CELLULITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/6/2003	7/6/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/2/2003	6/2/2003	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
JOHNNIE	JOHNNIE	NNP	B-NP	O
REED	REED	NNP	I-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
GMS	GMS	NNP	B-NP	O
Vo	Vo	NNP	I-NP	O
Rochena	Rochena	NNP	I-NP	O
Fortwardport	Fortwardport	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Osteomyelitis	Osteomyelitis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cellulitis	Cellulitis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
and	and	CC	I-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

COPD	COPD	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
fem	fem	NN	I-NP	O
pop	pop	NN	I-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
,	,	,	O	O
1999	1999	CD	B-NP	O
fem	fem	NN	I-NP	O
pop	pop	NN	I-NP	O
on	on	IN	B-PP	O
right	right	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
CAD	CAD	NN	I-NP	O
last	last	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
7/10	7/10	CD	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
73	73	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
last	last	JJ	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	O
A1c	A1c	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
7.7	7.7	CD	B-NP	O
in	in	IN	B-PP	O
9/18	9/18	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.3	1.3	CD	B-NP	O
to	to	TO	B-PP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
infections	infection	NNS	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
incision	incision	NN	I-NP	O
and	and	CC	O	O
drainage	drainage	NN	B-NP	O
and	and	CC	I-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
5th	5th	JJ	I-NP	O
left	left	JJ	I-NP	O
metatarsal	metatarsal	NN	I-NP	O
in	in	IN	B-PP	O
10/15	10/15	CD	B-NP	O
for	for	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
tendency	tendency	NN	I-NP	O
toward	toward	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
treated	treat	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
given	give	VBN	B-VP	O
allergies	allergy	NNS	B-NP	O
with	with	IN	B-PP	O
success	success	NN	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
surgical	surgical	JJ	B-NP	O
incisions	incision	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thighs	thigh	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
methicillin-resistant	methicillin-resistant	JJ	B-NP	O
staphylococcus	staphylococcus	NN	I-NP	O
aureus	aureus	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	IN	B-PP	O
API	API	NNP	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
discectomy	discectomy	NN	I-NP	O
and	and	CC	I-NP	O
laminectomy	laminectomy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
podiatrist	podiatrist	NN	I-NP	O
of	of	IN	B-PP	O
record	record	NN	B-NP	O
is	be	VBZ	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Kocieda	Kocieda	NNP	I-NP	O
His	His	NNP	I-NP	O
telephone	telephone	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
092-829-8896	092-829-8896	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66-year-old	66-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
autoimmune	autoimmune	JJ	B-NP	O
hemolytic	hemolytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
infections	infection	NNS	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
area	area	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
swelling	swelling	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
specifically	specifically	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
erythema	erythema	NN	B-NP	O
,	,	,	O	O
swelling	swelling	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
second	second	JJ	I-NP	O
toe	toe	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
foot	foot	NN	B-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
saw	see	VBD	B-VP	O
her	her	PRP$	B-NP	O
podiatrist	podiatrist	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
7/6/2003	7/6/2003	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
toe	toe	NN	I-NP	O
was	be	VBD	B-VP	O
drained	drain	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
yielding	yield	VBG	B-VP	O
pus	pus	NN	B-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
have	have	VBP	I-VP	O
increasing	increase	VBG	I-VP	O
erythema	erythema	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
all	all	DT	B-NP	O
the	the	DT	I-NP	O
way	way	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
shin	shin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dizziness	dizziness	NN	I-NP	O
or	or	CC	O	O
orthostatic	orthostatic	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
admitted	admit	VBN	I-VP	O
between	between	IN	B-PP	O
8/7/2003	8/7/2003	CD	B-NP	O
and	and	CC	I-NP	O
3/2/2003	3/2/2003	CD	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
COPD	COPD	NN	I-NP	B-DNA
flare	flare	NN	I-NP	I-DNA
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
anemia	anemia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
hemolyze	hemolyze	VB	I-VP	O
additionally	additionally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
that	that	DT	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Aramis	Aramis	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
during	during	IN	B-PP	O
that	that	DT	B-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	B-protein
upper	upper	JJ	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
splenic	splenic	JJ	B-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
plain	plain	JJ	B-NP	O
films	film	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
versus	versus	IN	B-PP	O
acute	acute	JJ	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
systems	system	NNS	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
urinary	urinary	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
mentioned	mention	VBD	B-VP	O
,	,	,	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
running	run	VBG	I-VP	O
high	high	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
250s	250	NNS	I-NP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
plantar	plantar	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
planned	plan	VBN	I-VP	O
on	on	IN	B-PP	O
having	have	VBG	B-VP	O
surgery	surgery	NN	B-NP	O
soon	soon	RB	B-ADVP	O
for	for	IN	B-PP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
Keflex	Keflex	NNP	B-NP	O
,	,	,	O	O
Ultram	Ultram	NNP	B-NP	O
,	,	,	O	O
Vancomycin	Vancomycin	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Linezolid	Linezolid	NN	B-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
Linezolid	Linezolid	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
gets	get	VBZ	B-VP	O
headaches	headache	NNS	B-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
Vancomycin	Vancomycin	NN	B-NP	O
hives	hive	NNS	I-NP	O
,	,	,	O	O
Ultram	Ultram	NNP	B-NP	O
produces	produce	VBZ	B-VP	O
systemic	systemic	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
nature	nature	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
to	to	TO	B-PP	O
Keflex	Keflex	NNP	B-NP	O
her	her	PRP$	B-NP	O
allergy	allergy	NN	I-NP	O
is	be	VBZ	B-VP	O
questionable	questionable	JJ	B-ADJP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
cephalosporins	cephalosporin	NNS	B-NP	O
and	and	CC	I-NP	O
penicillins	penicillin	NNS	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
by	by	IN	B-PP	O
report	report	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admitting	admit	VBG	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
colon	colon	NN	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
esophageal	esophageal	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
father	father	NN	I-NP	O
and	and	CC	I-NP	O
mother	mother	NN	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
nurse	nurse	NN	I-NP	O
at	at	IN	B-PP	O
Forestnew	Forestnew	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
She	She	NNP	I-NP	O
is	be	VBZ	B-VP	O
married	marry	VBN	I-VP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
one	one	CD	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
35-pack	35-pack	JJ	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
but	but	CC	O	O
she	she	PRP	B-NP	O
quit	quit	VBD	B-VP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
150/70	150/70	CD	B-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
,	,	,	O	O
afebrile	afebrile	RB	B-ADVP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
at	at	IN	B-PP	O
18	18	CD	B-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
notable	notable	JJ	I-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
bruit	bruit	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
inspiratory	inspiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
examination	examination	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Benign	Benign	JJ	B-ADJP	O
.	.	.	O	O

Back	Back	RB	B-ADVP	O
:	:	:	O	O
No	No	DT	B-NP	O
CVA	CVA	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
tense	tense	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ulcer	ulcer	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
plantar	plantar	NN	I-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
fluctuant	fluctuant	JJ	B-ADJP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
serosanguinous	serosanguinous	JJ	B-NP	O
drainage	drainage	NN	I-NP	O
and	and	CC	I-NP	O
erythema	erythema	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
circumferential	circumferential	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mid-shin	mid-shin	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
more	more	JJR	B-NP	O
tenderness	tenderness	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
malleolus	malleolus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
left	left	JJ	I-NP	O
calf	calf	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
questionable	questionable	JJ	I-NP	O
palpable	palpable	JJ	I-NP	O
cord	cord	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
erythema	erythema	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
second	second	JJ	I-NP	O
toe	toe	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
punctate	punctate	NN	I-NP	O
lesion	lesion	NN	I-NP	O
draining	drain	VBG	B-VP	O
serosanguinous	serosanguinous	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

Discontinuous	Discontinuous	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
interior	interior	JJ	I-NP	O
shin	shin	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
onychomycosis	onychomycosis	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
intradigital	intradigital	JJ	I-NP	O
ulceration	ulceration	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
4th	4th	JJ	I-NP	O
and	and	CC	I-NP	O
5th	5th	JJ	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
right	right	JJ	B-NP	O
calf	calf	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-ADJP	O
:	:	:	O	O
Neurological	Neurological	JJ	B-NP	O
was	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
and	and	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	B-cell_line
blood	blood	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
gram-positive	gram-positive	JJ	B-NP	B-protein
cocci	coccus	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
methicillin	methicillin	NN	B-NP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
collections	collection	NNS	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
2nd	2nd	NN	I-NP	O
and	and	CC	I-NP	O
3rd	3rd	NN	I-NP	O
metatarsal	metatarsal	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
chronic	chronic	JJ	B-NP	O
osteitis	osteitis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
calcaneous	calcaneous	JJ	I-NP	O
wounds	wound	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
phalanges	phalange	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
visualized	visualize	VBN	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
initially	initially	RB	B-ADVP	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
sensitivities	sensitivity	NNS	I-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
and	and	CC	O	O
instead	instead	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
dopthromycin	dopthromycin	NN	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Bactrim	Bactrim	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
and	and	CC	O	O
then	then	RB	O	O
to	to	TO	B-VP	O
p.o.	p.o.	VB	I-VP	O
Bactrim	Bactrim	NNP	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
TTE	TTE	NN	I-NP	O
on	on	IN	B-PP	O
2/21/2003	2/21/2003	CD	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
vegetation	vegetation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
debridement	debridement	NN	B-NP	O
on	on	IN	B-PP	O
10/19/2003	10/19/2003	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
material	material	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
culture	culture	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
sternal	sternal	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
,	,	,	O	O
dysphasia	dysphasia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
thrush	thrush	NN	I-NP	O
on	on	IN	B-PP	O
examination	examination	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
likely	likely	RB	B-ADVP	O
had	have	VBD	B-VP	O
oral	oral	JJ	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
steroid	steroid	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Diflucan	Diflucan	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
nystatin	nystatin	NN	I-NP	O
swish	swish	VB	B-VP	O
and	and	CC	I-VP	O
swallow	swallow	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
bone	bone	NN	I-NP	O
tissue	tissue	NN	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-NP	O
methicillin-resistant	methicillin-resistant	JJ	I-NP	O
staphylococcus	staphylococcus	NN	I-NP	O
aureus	aureus	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
beta-hemolytic	beta-hemolytic	JJ	B-NP	O
streptococcus	streptococcus	NN	I-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
once	once	RB	B-ADVP	O
again	again	RB	I-ADVP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
allergies	allergy	NNS	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
p.o.	p.o.	FW	B-NP	O
Bactrim	Bactrim	NNP	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
way	way	NN	I-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
these	these	DT	B-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/19/2003	3/19/2003	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Diflucan	Diflucan	NNP	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
nystatin	nystatin	NN	B-NP	O
swish	swish	VB	B-VP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
candidiasis	candidiasis	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
since	since	RB	I-VP	O
been	be	VBN	I-VP	O
improving	improve	VBG	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
being	be	VBG	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
stabilized	stabilize	VBN	I-VP	O
at	at	IN	B-PP	O
1.9	1.9	CD	B-NP	O
after	after	IN	B-PP	O
peaking	peak	VBG	B-VP	O
at	at	IN	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
follow	follow	JJ	B-NP	O
ups	up	NNS	I-NP	O
scheduled	schedule	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
physicians	physician	NNS	I-NP	O
on	on	IN	B-PP	O
1/27/2004	1/27/2004	CD	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continuing	continue	VBG	I-VP	O
her	her	PRP$	B-NP	O
Bactrim	Bactrim	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
6-week	6-week	JJ	I-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
weekly	weekly	JJ	B-NP	O
CBC	CBC	NN	I-NP	O
checks	check	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Sherman	Sherman	NNP	I-NP	O
Handel	Handel	NNP	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
autoimmune	autoimmune	JJ	B-NP	O
hemolytic	hemolytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematologist	hematologist	NN	I-NP	O
of	of	IN	B-PP	O
record	record	NN	B-NP	O
is	be	VBZ	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Bocanegra	Bocanegra	NNP	I-NP	O
On	On	IN	B-PP	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
transfusions	transfusion	NNS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
hemolyzed	hemolyze	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
although	although	IN	B-SBAR	O
her	her	PRP$	B-NP	O
hemolysis	hemolysis	NN	I-NP	B-protein
labs	lab	NNS	I-NP	I-protein
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
LDH	LDH	NN	I-NP	B-protein
and	and	CC	I-NP	O
bilirubins	bilirubin	NNS	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
steadily	steadily	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
38.8	38.8	CD	B-NP	O
to	to	TO	B-PP	O
27	27	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
increased	increase	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
LDH	LDH	NN	I-NP	B-protein
but	but	CC	O	O
no	no	DT	B-NP	O
schistocytes	schistocyte	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
on	on	IN	B-PP	O
smear	smear	NN	B-NP	O
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hemolyzing	hemolyze	VBG	I-VP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
given	give	VBN	B-PP	O
in	in	IN	B-PP	O
doses	dose	NNS	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
each	each	DT	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
successfully	successfully	RB	B-ADVP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
complications	complication	NNS	I-NP	O
or	or	CC	I-NP	O
transfusion	transfusion	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
is	be	VBZ	B-VP	O
36.0	36.0	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
4	4	CD	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
oral	oral	JJ	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
nebs	neb	NNS	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
for	for	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
COPD	COPD	NN	I-NP	O
exacerbations	exacerbation	NNS	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
periodically	periodically	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
improved	improve	VBN	I-VP	O
with	with	IN	B-PP	O
nebulizer	nebulizer	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
1/7/2003	1/7/2003	CD	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
bilateral	bilateral	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
fluid	fluid	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
so	so	IN	B-SBAR	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
lower	low	JJR	I-NP	O
lung	lung	NN	I-NP	O
field	field	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
pleuritic	pleuritic	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
LENIs	LENI	NNS	B-NP	B-protein
done	do	VBN	B-ADJP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PE	PE	NN	I-NP	B-protein
protocol	protocol	NN	I-NP	I-protein
CT	CT	NN	I-NP	I-protein
on	on	IN	B-PP	O
1/7/2003	1/7/2003	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
pleuritic	pleuritic	JJ	I-NP	B-protein
left	leave	VBD	B-VP	I-protein
lower	low	JJR	B-NP	I-protein
lobe	lobe	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
presumably	presumably	RB	B-ADVP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
situation	situation	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
once	once	RB	B-ADVP	O
again	again	RB	I-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
complete	complete	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
reviewed	review	VBN	I-VP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ribs	rib	NNS	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
tenderness	tenderness	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lung	lung	NN	I-NP	O
field	field	NN	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
ribs	rib	NNS	I-NP	O
were	be	VBD	B-VP	O
visualized	visualize	VBN	I-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Toprol	Toprol	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Diovan	Diovan	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
elevated	elevated	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
without	without	IN	B-PP	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
esophageal	esophageal	JJ	B-NP	O
spasm	spasm	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
nitroglycerine	nitroglycerine	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
0.25	0.25	CD	B-NP	O
on	on	IN	B-PP	O
random	random	JJ	B-NP	O
draw	draw	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
a	a	DT	B-NP	O
false	false	JJ	I-NP	O
positive	positive	JJ	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
thereafter	thereafter	RB	B-ADVP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
preoperative	preoperative	JJ	I-NP	O
MIBI	MIBI	NN	I-NP	O
on	on	IN	B-PP	O
10/11/2003	10/11/2003	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
territory	territory	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
ahead	ahead	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
surgery	surgery	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
with	with	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
block	block	NN	I-NP	O
,	,	,	B-PP	O
not	not	RB	I-PP	O
with	with	IN	B-PP	O
general	general	JJ	B-NP	O
anesthesia	anesthesia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Toprol	Toprol	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
75	75	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	RB	B-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
MIBI	MIBI	NN	I-NP	O
findings	finding	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
goal	goal	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
set	set	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
low-dose	low-dose	JJ	I-NP	B-protein
statin	statin	NN	I-NP	I-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
plan	plan	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
during	during	IN	B-PP	O
rehab	rehab	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
begin	begin	VB	I-VP	O
to	to	TO	I-VP	O
experience	experience	VB	I-VP	O
symptoms	symptom	NNS	B-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
cap	cap	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

Towards	Towards	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
boluses	bolus	NNS	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
transfusions	transfusion	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
went	go	VBD	B-VP	O
up	up	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
swelling	swelling	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
recurrences	recurrence	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
left-sided	left-sided	JJ	I-NP	I-protein
back	back	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lung	lung	NN	I-NP	O
field	field	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
before	before	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
improved	improve	VBN	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
is	be	VBZ	B-VP	O
1.3	1.3	CD	B-NP	O
to	to	TO	B-PP	O
1.4	1.4	CD	B-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	RB	I-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
dye	dye	NN	I-NP	O
load	load	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
scans	scan	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
2.7	2.7	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
Bactrim	Bactrim	NNP	I-NP	O
but	but	CC	O	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
trend	trend	VB	I-VP	O
down	down	RP	B-PRT	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
Bactrim	Bactrim	NNP	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
reasons	reason	NNS	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
likely	likely	RB	B-VP	O
increased	increase	VBD	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
were	be	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
dopthromycin	dopthromycin	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
Bactrim	Bactrim	NNP	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Ophthalmology	Ophthalmology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
Ophthalmology	Ophthalmology	NN	I-NP	O
team	team	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
left	left	JJ	I-NP	O
floater	floater	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
vitreous	vitreous	JJ	B-NP	O
hemorrhages	hemorrhage	NNS	I-NP	O
and	and	CC	O	O
questionable	questionable	JJ	B-NP	O
retinal	retinal	JJ	I-NP	O
detachment	detachment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
optic	optic	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
vitreous	vitreous	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
bed	bed	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
thereafter	thereafter	RB	B-ADVP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
curtains	curtain	NNS	B-NP	O
symptoms	symptom	NNS	I-NP	O
or	or	CC	O	O
spots	spot	NNS	B-NP	O
or	or	CC	I-NP	O
flashes	flash	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
Ophthalmology	Ophthalmology	NN	B-NP	O
be	be	VB	B-VP	O
reconsulted	reconsulte	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
complained	complain	VBN	I-VP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	B-protein
upper	upper	JJ	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
when	when	WRB	B-ADVP	O
initially	initially	RB	B-ADVP	O
checked	check	VBN	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
by	by	IN	B-PP	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
since	since	IN	B-PP	O
these	these	DT	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Bactrim	Bactrim	NNP	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
trending	trend	VBG	I-VP	O
down	down	RP	B-PRT	O
since	since	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
very	very	RB	I-VP	O
tender	tender	VB	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
on	on	IN	B-PP	O
10/19/2003	10/19/2003	CD	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
enlarged	enlarged	JJ	I-NP	O
liver	liver	NN	I-NP	O
alkaline	alkaline	NN	I-NP	O
phosphatase	phosphatase	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	B-protein
upper	upper	JJ	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
improved	improve	VBN	B-VP	O
subsequently	subsequently	RB	B-ADVP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
antibiotic	antibiotic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Folate1	Folate1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	B-protein
5000	5000	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
p.o.	p.o.	FW	B-NP	I-protein
b.i.d.	b.i.d.	FW	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
50	50	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Nystatin	Nystatin	NN	B-NP	O
suspension	suspension	NN	I-NP	O
10	10	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
swish	swish	VB	B-VP	O
and	and	CC	I-VP	O
swallow	swallow	VB	I-VP	O
q.i.d.	q.i.d.	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
:	:	:	O	O
If	If	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
200	200	CD	B-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
201-250	201-250	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
251-300	251-300	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
301-350	301-350	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
351-400	351-400	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
and	and	CC	O	O
call	call	NN	B-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
tablet	tablet	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Zocor	Zocor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Bactrim	Bactrim	NNP	B-NP	O
Double	Double	NNP	I-NP	O
Strength	Strength	NNP	I-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
6-week	6-week	JJ	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
end	end	VB	I-VP	O
on	on	IN	B-PP	O
9/13/2003	9/13/2003	CD	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Flovent	Flovent	NN	B-NP	O
200	200	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Caltrate	Caltrate	NN	B-NP	O
plus	plus	CC	I-NP	O
Vitamin	Vitamin	NN	I-NP	O
D	D	NN	I-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Duonebs	Duoneb	NNS	B-NP	O
3/0	3/0	CD	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulized	nebulize	VBN	I-NP	O
treatments	treatment	NNS	I-NP	O
q.	q.	RB	B-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Saline	Saline	NN	B-NP	O
eye	eye	NN	I-NP	O
drops	drop	VBZ	B-VP	O
2	2	CD	B-NP	O
drops	drop	NNS	I-NP	O
o.u.	o.u.	IN	B-PP	O
t.i.d.	t.i.d.	NN	B-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
2	2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

Aramis	Aramis	IN	B-PP	O
200	200	CD	B-NP	O
mcg	mcg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
q.	q.	NN	I-NP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
dose	dose	NN	I-NP	O
1/7/2003	1/7/2003	CD	I-NP	O
;	;	:	O	O
next	next	JJ	B-NP	O
dose	dose	NN	I-NP	O
due	due	JJ	B-ADJP	O
4/15/2003	4/15/2003	CD	B-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
21	21	CD	I-NP	I-protein
.	.	.	O	O

Artificial	Artificial	NNP	B-NP	O
Tear	Tear	NNP	I-NP	O
Drops	Drops	NNP	I-NP	O
2	2	CD	I-NP	O
drops	drop	VBZ	B-VP	O
o.u.	o.u.	NN	B-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
PRN	PRN	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
headache	headache	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
nebulized	nebulize	VBD	B-VP	O
treatments	treatment	NNS	B-NP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	VBP	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Dulcolax	Dulcolax	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Maalox	Maalox	NNP	B-NP	O
Plus	Plus	NNP	I-NP	O
15	15	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
indigestion	indigestion	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Milk	Milk	NNP	B-NP	O
of	of	IN	B-PP	O
Magnesia	Magnesia	NNP	B-NP	O
30	30	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Dulcolax	Dulcolax	IN	B-PP	O
suppository	suppository	JJ	B-NP	O
10-20	10-20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.r.	p.r.	RB	B-ADVP	O
b.i.d.	b.i.d.	VBP	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Toby	Toby	NNP	I-NP	O
Nadel	Nadel	NNP	I-NP	O
,	,	,	O	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
for	for	IN	B-PP	O
checking	check	VBG	B-VP	O
CBC	CBC	NN	B-NP	B-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
team	team	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
FAX	FAX	NNP	B-NP	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
the	the	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
attending	attend	VBG	B-VP	O
at	at	IN	B-PP	O
444-622-0960	444-622-0960	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
attending	attending	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Cletus	Cletus	NNP	I-NP	O
Almario	Almario	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
1/27/2004	1/27/2004	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	SYM	O	O
30	30	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
at	at	IN	B-PP	O
Ein	Ein	NNP	B-NP	O
Mid-comp	Mid-comp	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
requires	require	VBZ	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Orthopedic	Orthopedic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tavares	Tavares	NNP	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Raby	Raby	NNP	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
and	and	CC	O	O
set	set	VB	B-VP	O
up	up	RP	B-PRT	O
this	this	DT	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

INTERIM	INTERIM	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
FOR	FOR	IN	B-PP	O
REHABILITATION	REHABILITATION	NNP	B-NP	O
FACILITY	FACILITY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
check	check	NN	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
daily	daily	JJ	I-NP	O
weight	weight	NN	I-NP	O
and	and	CC	O	O
adjust	adjust	VBP	B-VP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
clinical	clinical	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
check	check	NN	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
CBC	CBC	NN	I-NP	B-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
weekly	weekly	JJ	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
receiving	receive	VBG	I-VP	O
Bactrim	Bactrim	NNP	B-NP	O
p.o.	p.o.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
monitor	monitor	NN	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
feet	foot	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
change	change	VB	B-VP	O
dressings	dressing	NNS	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-9119543	1-9119543	CD	B-NP	O
VSSten	VSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
FLITTON	FLITTON	NNP	B-NP	O
,	,	,	O	O
FEDERICO	FEDERICO	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
THIBERT	THIBERT	NNP	B-NP	O
,	,	,	O	O
VITO	VITO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0024750	0024750	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/21/03	1/21/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/21/03	1/21/03	CD	B-NP	O

